这种成分是什么?

이 원료는 다음의 구조를 갖는 유기 화합물이다.

成分列表

成分词典

ALPHA-IONONE

Alpha-ionone is an ionone, an enone and a methyl ketone.

产品中实际含有多少

暂无产品标示该成分含量。

含该成分的产品中，1 款将其列在 1% 线之前，10 款列在之后（通常不超过 1%）。

含有此成分的产品

已确认 11 款中的 11 款 · 按含量充足程度排序

定义

Alpha-ionone is an ionone, an enone and a methyl ketone.

来源: PubChem

美国FDA 物质登记 · UNII I9V075M61R · 登记名称 α-Ionone · 单一化学物质

来源: 美国FDA 物质识别码（UNII）

化妆品中的作用

为产品增添香味PERFUMING

安全与法规参考

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息（环境公团）

详细资料——标示名称、识别编号、物性、试验记录、文献

别名和识别信息

ALPHA-IONONEINCI알파-아이오논韩国标示名称（食药处标准名）3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, (E)-同义名

CAS No.化学物质登记号: 127-41-3
EC No.欧盟化学品目录编号: 204-841-6
DTXSID美国EPA化学品编号: DTXSID0035160
DTXCID美国EPA化合物编号: DTXCID8015160

IUPAC: (3E)-4-(2,6,6-Trimethylcyclohex-2-en-1-yl)but-3-en-2-one
分子式: C13H20O
分子量: 192.302 g/mol

实测物性

性状: Liquid, CBI · colourless to pale-yellow liquid with a warm, woody, violet-floral odour
气味: It has a warm, woody, floral odor with balsamic and sweet tones and is strongly reminiscent of violet flowers. · Sweet-floral odor, reminiscent of violets
沸点: 258 °C at 760 mm Hg · Pale yellow to yellow liquid, Specific gravity: 0.933-0.937 25/25 °C, Boiling point: 126-128 °C at 12 mm Hg /mixed ionone isomers/
溶解性: In water, 106 mg/L at 25 °C · Soluble in alcohol, most fixed oils, propylene glycol, insoluble in glycerin
密度: 0.9319 at 20/4 °C · 0.927-0.933
稳定性: Stable under recommended storage conditions.
颜色: 无色
熔点/凝固点: &amp, lt, 25 ℃
初沸点和沸程: 131 ℃
闪点: 118 ℃
溶解度: 1000000 ㎎/ℓ (25 deg c)
比重: 0.93
正辛醇/水分配系数（Kow）: 3.85

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

来源: PubChem · 韩国安全保健公团安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 20 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

Fragrance16
Flavouring and nutrient2
Deodorizer2

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 6 项、眼部试验 5 项。

归类为低8 项

试验结论基本一致（100%）。这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 11 项试验

Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: as mentioned below
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: as mentioned below according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: as mentioed below
Not likely to be sensitizing
skin sensitisation · Screening · according to other guideline: as mentioned below
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: as mentioned below.
Category 6.4A (Category 2A)
Eye Irritation · Read Across
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Draize method according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Draize Method according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: as mentioned below equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to